Plus   Neg

Lennox International Reiterates FY20 Outlook - Quick Facts

While reporting financial results for the fourth quarter on Tuesday, Lennox International Inc. (LII) reiterated its earnings and revenue growth outlook for the full-year 2020.

For fiscal 2020, Lennox continues to project earnings and adjusted earnings from continuing operations in a range of $11.30 to $11.90 per share, on adjusted revenue growth of 4 to 8 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $11.61 per share on a revenue growth of 5.6 percent to $3.98 billion for the year. Analysts' estimates typically exclude special items.

"We introduced new products in 2019 and continued to make investments for future growth and profitability that position the company well for 2020 and beyond," said Chairman and CEO Todd Bluedorn.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT